← Back to headlines
Merck's Investment Boosts Funding for Vaginal Drug Delivery Research
Merck has significantly impacted the funding landscape for vaginal drug delivery, addressing a previous lack of investment in the area.
20 Apr, 11:00 — 20 Apr, 11:00
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
2h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
6h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago